Prescription drug · NDA
Ferriprox (Deferiprone) NDC 10122-101
Deferiprone 100 mg/mL · Solution · Oral · Chiesi USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 10122-101-50 | 1012201015010122010150 | 500 mL in 1 BOTTLE, PLASTIC (10122-101-50)Marketed from Jan 1, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ferriprox
- Generic name (nonproprietary)
- deferiprone
- Active ingredients
- Deferiprone — 100 mg/mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Chiesi USA, Inc.NDC labeler code 10122
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208030
- Marketing start
- Listing expires
- Other FDA classes
- Iron Chelating Activity (Mechanism)
- Identifiers
- Product ID 10122-101_3ec2a1ae-4ca9-43b3-a3e2-2b79c2a34172SPL ID 3ec2a1ae-4ca9-43b3-a3e2-2b79c2a34172SPL set ID f057cf4d-b06f-4fbd-aa2e-68c5e4d8a846RxCUI 1716264, 1716268UNII 2BTY8KH53L
- Pharmacologic class
- Iron Chelator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N410122010150followed by a unit qualifier and the quantityPackage 10122-0101-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
FERRIPROX Oral Solution is indicated for the treatment of transfusional iron overload in adult and pediatric patients 3 years of age and older with thalassemia syndromes, sickle cell disease or other anemias. FERRIPROX Oral Solution is an iron chelator indicated for the treatment of transfusional iron overload in adult and pediatric patients 3 years of age and older with thalassemia syndromes, sickle cell disease or other anemias. ( 1 ) Limitations of Use Safety and effectiveness have not been established for the treatment of transfusional iron overload in patients with myelodysplastic syndrome or in patients with Diamond Blackfan anemia. Limitations of Use Safety and effectiveness have not …
Excerpt only. Read the full label for complete information.
About NDC 10122-101
- What is NDC 10122-101?
- 10122-101 is the product NDC for Ferriprox (deferiprone), Deferiprone 100 mg/mL solution, listed with the FDA by Chiesi USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ferriprox (Deferiprone).
- What is the active ingredient?
- Deferiprone.
- Who is the labeler?
- Chiesi USA, Inc., NDC labeler code 10122. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ferriprox?
- 2 other product NDCs are listed under this name. See all Ferriprox NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ferriprox products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ferriproxdeferiprone | Deferiprone 1000 mg/1 | TabletOral | Chiesi USA, Inc. | 10122-104 | 10122-0104-0110122-0104-05 |
| Ferriproxdeferiprone | Deferiprone 1000 mg/1 | Tablet, Film coatedOral | Chiesi USA, Inc. | 10122-103 | 10122-0103-05 |